Ovarian Cancer Clinical Trial
Avelumab Program Rollover Study
Summary
The main purpose of this study is to monitor the safety and tolerability of avelumab in participants with solid tumors who continue treatment with avelumab under the same treatment regimen as in the parent avelumab study.
Eligibility Criteria
Inclusion Criteria:
Participants under enrollment and treatment in an avelumab clinical study under the sponsorship of EMD Serono Research & Development Institute, Inc. / Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd (Japan)
Participants currently enrolled in an avelumab parent study and are on active treatment with avelumab or in long-term survival follow-up after treatment
Participants on active treatment must agree to continue to use highly effective contraception (that is, methods with a failure rate of less than 1% per year) for both male and female participants if the risk of conception exists
Other protocol defined inclusion criteria could apply.
Exclusion Criteria:
Participants who are pregnant or breastfeeding
Participants still on active treatment: Known hypersensitivity to any of the study intervention ingredients
Participant has been enrolled in the comparator arm of avelumab parent study
Participant has been withdrawn from avelumab parent study for any reason
Any other reason that, in the opinion of the Investigator, precludes the participant from participating in the study
Other protocol defined exclusion criteria could apply.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 24 Locations for this study
Scottsdale Arizona, 85258, United States
Fayetteville Arkansas, 72703, United States
Sacramento California, 95817, United States
Santa Rosa California, 95403, United States
Santa Rosa California, 95403, United States
Norwalk Connecticut, 06850, United States
Port Saint Lucie Florida, 34952, United States
Marietta Georgia, 30060, United States
Rockville Maryland, 20850, United States
Lansing Michigan, 48910, United States
Minneapolis Minnesota, 55407, United States
Kansas City Missouri, 64131, United States
Cincinnati Ohio, 45229, United States
Cincinnati Ohio, 45242, United States
Cincinnati Ohio, 45242, United States
Columbus Ohio, 43210, United States
Portland Oregon, 97201, United States
Providence Rhode Island, 02903, United States
Charleston South Carolina, 29425, United States
Greenville South Carolina, 29605, United States
Germantown Tennessee, 38138, United States
Nashville Tennessee, 37203, United States
Dallas Texas, 75390, United States
Houston Texas, 77030, United States
San Antonio Texas, 78229, United States
Burlington Vermont, 05401, United States
Cordoba , , Argentina
Ballarat , , Australia
Clayton , , Australia
Libramont , , Belgium
Liège , , Belgium
Barretos , , Brazil
Benesov , , Czechia
Brno , , Czechia
Besancon Cedex , , France
Lille cedex , , France
Nantes Cedex 01 , , France
Nantes Cedex 01 , , France
Nice , , France
Paris Cedex 05 , , France
Pessac , , France
Pessac , , France
Poitiers cedex , , France
Strasbourg Cedex , , France
Toulouse Cedex 9 , , France
Essen , , Germany
Gyor , , Hungary
Padova , , Italy
Roma , , Italy
Roma , , Italy
Rozzano , , Italy
Chuo-ku , , Japan
Chuo-ku , , Japan
Habikino-shi , , Japan
Koto-ku , , Japan
Kurume-shi , , Japan
Osaka-shi , , Japan
Suita-shi , , Japan
Daejeon , , Korea, Republic of
Seoul , , Korea, Republic of
Seoul , , Korea, Republic of
Seoul , , Korea, Republic of
Seoul , , Korea, Republic of
Cluj Napoca , , Romania
Oradea , , Romania
Saint-Petersburg , , Russian Federation
Saint-Petersburg , , Russian Federation
Ankara , , Turkey
Istanbul , , Turkey
Istanbul , , Turkey
Izmir , , Turkey
Mersin , , Turkey
London , , United Kingdom
Northwood , , United Kingdom
Plymouth , , United Kingdom
How clear is this clinincal trial information?